Baird Financial Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-57,283
| Closed | -$320K | – | 1896 |
|
|
2022
Q1 | $320K | Buy |
57,283
+5,154
| +10% | +$28.8K | ﹤0.01% | 1593 |
|
|
2021
Q4 | $244K | Sell |
52,129
-5,001
| -9% | -$23.4K | ﹤0.01% | 1757 |
|
|
2021
Q3 | $353K | Sell |
57,130
-2,055
| -3% | -$12.7K | ﹤0.01% | 1607 |
|
|
2021
Q2 | $390K | Buy |
59,185
+5,753
| +11% | +$37.9K | ﹤0.01% | 1492 |
|
|
2021
Q1 | $391K | Buy |
+53,432
| New | +$391K | ﹤0.01% | 1428 |
|
|
2019
Q4 | – | Sell |
-9,863
| Closed | -$83K | – | 1578 |
|
|
2019
Q3 | $83K | Buy |
+9,863
| New | +$83K | ﹤0.01% | 1485 |
|